2749 East Parleys Way
Suite 200
Salt Lake City, UT 84109
United States
801 990 0520
https://seraprognostics.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 55
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Ms. Evguenia Lindgardt M.B.A. | President, CEO & Director | 37.5k | N/A | 1974 |
Dr. Gregory C. Critchfield M.D., M.S. | Executive Director | 790.74k | N/A | 1953 |
Dr. Steven W. Graves | Co-Founder and Co-Chairman of The Scientific Advisory Board | N/A | N/A | N/A |
Dr. M. Sean Esplin M.D. | Co-Founder and Co-Chairman of Scientific Advisory Board | N/A | N/A | N/A |
Mr. Austin Aerts | Chief Financial Officer?? | N/A | N/A | N/A |
Dr. John J. Boniface Ph.D. | Chief Scientific Officer | 386.69k | N/A | 1962 |
Mr. Robert G. Harrison | Chief Information Officer | 384.18k | N/A | 1966 |
Mr. Benjamin G. Jackson J.D. | General Counsel | 410.75k | N/A | 1979 |
Dr. Paul Kearney Ph.D. | Chief Data Officer | N/A | N/A | 1968 |
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sera Prognostics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.